A multicentre Phase II study of non-pegylated liposomal doxorubicin in combination with trastuzumab and docetaxel as first-line therapy in metastatic breast cancer
Titel:
A multicentre Phase II study of non-pegylated liposomal doxorubicin in combination with trastuzumab and docetaxel as first-line therapy in metastatic breast cancer
Auteur:
Venturini, M. Bighin, C. Puglisi, F. Olmeo, N. Aitini, E. Colucci, G. Garrone, O. Paccagnella, A. Marini, G. Crinò, L. Mansutti, M. Baconnet, B. Barbato, A. Del Mastro, L.